chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.44
Sex: M
Vaccine: PNC
Symptoms: Aggression, Insomnia, Irritability, Rash, Urticaria
Clinical narrative: After Prevnar #1 and #2 - irritability, kicking, sleepless and hive-like to sunburn rash over entire body lasting 72 hours
Age: 1.01
Sex: M
Vaccine: HEP, HIBV
Symptoms: Autism
Clinical narrative: This case was considered medically important (OMIC). Information regarding Hib-Titer vaccine was received from a consumer regarding a 17 month old male patient who, at 12 months of age, on 11/4/02, received a fourth dose of Hib-Titer. On the same day, the patient also received a third dose of hepatitis B vaccine. In April 2003, the patient developed autism. No significant medical history or conditions. Indication for Hib-Titer vaccine was immunization. Product was administered on 11/4/02. Dose regimen was 1 dose (IM). Additional suspect vaccines included Polio Vaccine, Acel-Imune Vaccine and hepatitis B vaccine. Concomitant medications were not reported. On 11/4/02, the patient received a fourth dose of Hib-Titer vaccine, and in April 2003, developed autism. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 17.0
Sex: F
Vaccine: TYP
Symptoms: Abdominal pain, Nausea
Clinical narrative: Mother states patient took first dose of oral typhoid at 8 AM and waited 1 hour to eat, then exactly 2 hours after dose became nauseated and had abdominal cramping. Denies any fever or diarrhea. Felt better the evening of 02/20/05.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Rash
Clinical narrative: Patient called office with complaint of rash all over, the size of silver dollars. Office was busy, advised to go to the emergency department as soon as possible.
Age: 1.5
Sex: F
Vaccine: PNC
Symptoms: Pyrexia
Clinical narrative: On 02/15/2005, patient returned to the office mom reported temperature of 102 ath home that morning. Afebrile in office.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Unevaluable event
Clinical narrative: None listed.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Dyspnoea, Musculoskeletal stiffness, Throat tightness
Clinical narrative: A report received from a health care professional on 02Dec02, concerning a 43 year old female vaccinee who experienced chest tightness, difficulty breathing and muscle tenseness in the neck and shoulder region after receiving Fluvirin on 31Oct02. On 31Oct02, the vaccinee experienced chest tightness, difficulty breathing and muscle tenseness in the neck and shoulder region within approx 30 minutes of receiving Fluvirin. The vaccinee was brought to an emergency dept approx 3.5 hours after vaccination. However, by the time the vaccinee was seen in the emergency dept the symptoms had subsided and no treatment was administered. At the time of reporting the vaccinee had fully recovered with no sequelae. The vaccinee has received unspecified influenza vaccinations for approx the past 4-5 years with no prior adverse reactions. The reporter has assessed the relationship of the vaccine to the event as probable. Update 1, 31Jan03: A follow up report was received from a health care professional. The vaccinee received Fluvirin at 9:25 on 31Oct02. At 9:45 the vaccinee experienced a stiff neck at 10:15 she experienced a tightness in her throat, at 10:30 she experienced a tightness in her chest and at 10:45 she experienced a pressure/weight on her chest making it difficult for her to breathe. The event was reported as life threatening and required medical/surgical intervention. The vaccinee was transported to an ER for observation. The events resolved on the 31Oct02.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Hypoaesthesia, Trigeminal neuralgia
Clinical narrative: A report was received from a health care professional on 26Nov02 concerning a 36 year old female vaccinee who experienced left facial numbness after receiving Fluvirin on 06Nov02. On 06Nov02 the vaccinee experienced facial numbness on the left side of her face extending from the middle of the cheek to her upper lip. The vaccinee underwent an MRI scan which was normal. The treating ENT physician stated that the numbness affected the trigeminal nerve. The numbness had not resolved at the time of the report. The reporter has assessed the relationship of the vaccine to the event as possible.
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Unintended pregnancy, White blood cell count increased
Clinical narrative: A report was received from a healthcare professional on 11Nov02 concerning a 25 year old female vaccinee who experienced an increased WBC count and was 30 weeks pregnant when she received Fluvirin on 08Nov02. On 08Nov02 the vaccinee was 30 weeks pregnant and received 0.5ml Fluvirin IM. On 11Nov02 the reporter ( a nurse) ordered a complete blood count test and noticed that the WBC was increased to 20.8. The clinics protocol specifies 4.0-11.0 as normal. It was reported that the vaccinee did not experience any adverse reaction. The vaccinee had not been vaccinated prior to this event. The reporter has classified the relationship of the event to the vaccine as possible.
Age: 20.0
Sex: M
Vaccine: FLU3
Symptoms: Hypersensitivity, Influenza like illness, Myalgia, Urticaria
Clinical narrative: A report was received from a consumer on 12Nov02 concerning a 20 year old male vaccinee who experienced hives and flu-like symptoms including fever and aches after receiving Fluvirin on 07Nov02. On 08Nov02, the vaccinee experienced hives and flu-like symptoms after receiving Fluvirin on 07Nov02. On 09Nov02 the vaccinee sought medical attention at an infirmary. The vaccinee was injected with diphenhydramine and released. Symptoms continued at the time of the report. The vaccinee was reported to be allergic to the sulfa drugs.
Age: 10.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site oedema, Similar reaction on previous exposure to drug, Skin discolouration, Tenderness
Clinical narrative: A report was received from a healthcare professional on 12Nov02 concerning a 10 year old female vaccinee who experienced redness, swelling, purple discoloration and tenderness around the injection site within 1 day of receiving Fluvirin on 08Nov02. On 09Nov02 the vaccinee experienced redness, swelling, purple discoloration and tenderness within 1 day of receiving Fluvirin. Symptoms included redness, swelling, purple discoloration and tenderness of an 8cm area around the injection site. The symptoms were relieved by Benadryl topical cream and cold compress. On 11nov02 the vaccinee had not yet recovered. The vaccinees father indicated that the vaccinee received an influenza vaccine (brand unspecified) on the previous year and experienced a mild local reaction at the injection site. The reporter has assessed the relationship of the vaccine to the event as probable.
Age: 64.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Facial palsy
Clinical narrative: A report was received from a healthcare professional on 12Nov02 concerning a 64 year old male vaccinee who experienced chills immediately after receiving Fluvirin and developed Balls Palsy 3 days after vaccination on 02Nov02. Immediately after receiving 0.5ml Fluvirin IM the vaccinee experienced chills which resolved on an unreported date. 3 days after receiving Fluvirin the vaccinee developed Bells Palsy with drooping of the left eye and the left side of the face and lips. Symptoms had not resolved at the time of the report. There was insufficient information to determine the reporter's causality assessment.
Age: 9.0
Sex: M
Vaccine: FLU3
Symptoms: Insomnia
Clinical narrative: A report received from a parent of a consumer on 11/12/2002, concerning a 9 year old vaccinee who experienced insomnia within days of receiving Fluvirin on 11/01/2002. The vaccinee experienced insomnia within days of receiving Fluvirin. the vaccinee experienced difficulty in falling asleep on 3 different occasions (dates unknown). Nothing had changed in the vaccinee's daily routine or medications. At the time of reporting, the vaccinee had not yet recovered.
Age: 2.17
Sex: F
Vaccine: FLU3
Symptoms: Medication error, Pyrexia, Tenderness
Clinical narrative: A report was received from a health care professional on 11/13/2002, concerning a 26 month old female vaccinee who was inadvertently administered Fluvirin on 11/13/2002. On 11/13/2002, the vaccinee was inadvertently administered Fluvirin subcutaneously instead of polio vaccine. The vaccinee had not received any previous influenza vaccinations. The vaccinee did not experience any adverse reactions. There was insufficient information to determine the reporter's causality assessment. Update 1 01/27/2003 - A report was received from a health care professional concerning a vaccinee of less than 6 months old who experienced a mild temperature and slight tenderness at the injection site after receiving Fluvirin.
Age: 48.0
Sex: M
Vaccine: FLU3
Symptoms: Myalgia, Pyrexia, Rash erythematous, Rash maculo-papular
Clinical narrative: A report received from a health care professional on 11/13/2002, concerning a 48 year old male vaccinee who experienced an erythematous maculo-papular rash, low grade fever and myalgia 4 days after receiving Fluvirin on 11/08/02. On 11/12/02, the vaccinee experienced an erythematous maculo-papular rash, low grade fever and myalgia 4 days after receiving Fluvirin. The erythematous maculo-papular rash developed all over his body. The vaccinee was treated with Tylenol and Benadryl (OTC strength). At the time of reporting the vaccinee had not yet recovered. The reporter has assessed the relationship of the vaccine to the event as probable and that the vaccinee experienced a hypersensitivity to Fluvirin.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Malaise, Sneezing
Clinical narrative: A report received from a health care professional 11/13/2002, concerning a 62 year old vaccinee who experienced sneezing and malaise 3 hours after receiving Fluvirin on 11/12/2002. On 11/12/2002, the vaccinee experienced sneezing and malaise 3 hours after receiving Fluvirin. The reporter indicated that the vaccinee started sneezing similar to symptoms of an allergic reaction 2 hours after receiving the vaccine. Furthermore, the vaccinee developed a general feeling of malaise that accompanied the sneezing. On 11/13/2002, 24 hours after the onset of the event, the sneezing and malaise spontaneously resolved without treatment. The reporter has assessed the relationship of the vaccine to the event as possible.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/13/2002 concerning a 67 year old female vaccinee who was inadvertently administered last years (2001) batch of Fluvirin on 11/13/2002. On 11/13/2002 the vaccinee received 0.5 ml of the 2001 batch of Fluvirin intramuscularly. No adverse reaction was reported in relation to the incident. The reporter has assessed the relationship of the event to the vaccine as related.
Age: 29.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report from a health care professional on 11/08/02, concerning a 29 year old female vaccinee who inadvertently received 0.5 mil Fluvirin with a TB syringe and may have received the vaccinee subcutaneously on 11/11/02. The reporter speculated that the vaccinee may have received Fluvirin via the subcuataneous route. The vaccinee did not experience any adverse events. There was insufficient information to determine the reporter's causality assessment.
Age: 38.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a health care professional on 11/08/2002, concerning a 38 year old male vaccinee who inadvertently received 0.5 ml Fluvirin with a TB syringe and may have received the vaccine subcutaneously on 11/11/2002. On 11/11/2002, the vaccinee was administered Fluvirin with a TB syringe. The reporter speculated that the vaccinee may have received the Fluvirin via the subcutaneous route. The vaccinee did not experience any adverse events. There was insufficient information to determine the reporter's causality assessment.
Age: 45.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Malaise, Pain, Urticaria
Clinical narrative: A report was received from a distributor on 11/13/02, concerning a 45 year old female vaccinee who experienced a aching arm, felt unwell and broke out in red hives on her legs, chest, lower back and neck after receiving Fluvirin on 11/06/02. On 11/06/02, the vaccine received a pneumonia shot in her left arm and a flue vaccine in her right arm. Later that evening she experienced a pain in her right arm. On 11/07/02 the vaccinee did not feel well all day. On 11/08/02 she broke out in red hives on her legs, chest, lower back and neck. The vaccinee was treated by a doctor and was given an injection of Triamcinolone. She was also prescribed methylprednisolone and hydroxyzine. On 11/13/02, the vaccinee had fully recovered from the reaction. There was insufficient information to determine the reporter's causality assessment.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/23/2002, concerning a female vaccinee of unknown age who inadvertently received frozen Fluvirin vaccine on 10/23/02. The vaccinee did not experience any adverse event. There was insufficient information to determine the reporter's causality assessment. Cross reference with PJP200200585, PJP200200629 and PJP200200775. Update (1) 12/23/02: A follow up report received from a health care professional indicated that the event was resolved on an unspecified date.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health professional on 10/23/2002, concerning a female vaccinee of unknown age who inadvertently received frozen Fluvirin vaccine on 10/23/2002. The vaccine did not experience any adverse event. There was insufficient information to determine the reporter's causality assessment. Cross reference with PJP200200585, PJP200200629 and PJP200200774. Update (1) 12/23/2002: A follow up report received from a health care professional indicated that the event was resolved on an unspecified date.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a health care professional on 11/15/02, concerning three vaccinee's of less than 4 years of age who were inadvertently administered Fluvirin on an unknown date. It was unknown whether or not any of the vaccinee's experienced an adverse event. There was insufficient information to determine the reporter's causality assessment.
Age: 21.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a health care professional on 11/15/02, concerning a female vaccinee who was inadvertently administered 9.5 ml of Fluvirin on 11/15/02. No adverse symptoms were reported. There was insufficient information to determine the reporter's causality assessment. Update (1) 01/07/03: A follow up report from a health care professional which indicated that the vaccinee was 20 years of age. The vaccinee inadvertently self administered 9.5 ml of Fluvirin. The vaccinee did not experience any adverse reactions.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: A report received from a health care professional on 11/18/02, concerning a 50 year old female vaccinee who experienced an injection site reaction after receiving Fluvirin on 10/22/02. On 10/22/02, the vaccinee experienced an injection site reaction after receiving Fluvirin on the same day. Symptoms included a 2-3 inch area of redness, swelling and warmth at the site of injection. The vaccinee was treated with diphenhydramine cream for 1 day, and the event resolved after one week. There was insufficient information to determine the reporter's causality assessment.
Age: 81.0
Sex: F
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: A report was received from a health professional on 11/18/02, concerning an 81 year old female who experienced a rash under both breast after receiving Fluvirin on 11/15/02. The event occurred on 11/16/02 or 11/17/02. At the time of reporting the vaccinee had not yet recovered. There was insufficient information to determine the reporter's causality assesement.
Age: 24.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Rash
Clinical narrative: A report was received from a health care professional on 11/18/02 concerning a 24 year old female vaccinee who experienced itching all over the body and a rash on the face 1 day after receiving Fluvirin on 11/15/02. The vaccinee was reported to be recovering after treatment with diphenhydramine. There was insufficient information to determine the reporter's causality assessment. Cross reference with: PJP200200793, PJP200200792 and PJP200200795.
Sex: U
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: A report was received from a health care professional on 11/18/02 concerning a vaccinee of unknown demography who developed a rash after receiving Fluvirin on an unknown date. No further information was reported. There was insufficient information to determine the reporter's causality assessment. Cross reference with: PJP200200794, PJP200200793 and PJP200200792.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/18/02 concerning a group of vaccinees who were inadvertently administered 0.5ml Fluvirin subcutaneously on unreported dates. The reporter has assessed the relationship of the event to the vaccine as unclassifiable.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Muscle atrophy
Clinical narrative: A report was received from a health care professional on 11/18/02, concerning a 46 year old female vaccinee, who was also a health care professional, who experienced muscle degradation and pain at the injection site 7 days after receiving Fluvirin on 10/30/02. On 11/06/02, the vaccinee experienced muscle degradation and pain at the injection in the left deltoid muscle. The degradation was reported to be worsening, involving an area of 5cm. In 1998 the vaccinee was reported to have had a similar experience after receiving influenza virus vaccine (brand unspecified). However, the vaccinee was reported to have tolerated influenza vaccinee (brands unspecified) in the past. The reporter has assessed the relationship of the event to the vaccine as possible.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 19Nov02 concerning a group of less than 10 vaccinees all less than 4 years old who were inadvertently administered Fluvirin on various unreported dates. On unreported dates less than 10 vaccinees less than 4 years were inadvertently administered Fluvirin. No adverse reaction was reported. There was insufficient information to determine the reporter's causality assessment.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a health care professional on 20Nov02, concerning a female vaccinee who inadvertently received Fluvirin SC on 20Nov02. On 20Nov02, the vaccinee was inadvertently administered Fluvirin SC. No adverse symptoms were reported. There was insufficient information to determine the reporters causality assessment.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 11/20/2002 concerning a female vaccinee who was inadvertently administered 0.1ml Fluvirin subcutaneously on 11/20/2002.  On 11/20/2002 the vaccinee was inadvertently administered 0.1ml Fluvirin subcutaneously instead of a PPD test.  No adverse effect was reported. There was insufficient information to determine the reporter's causality assessment.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Muscular weakness, Swelling
Clinical narrative: A report was received from a health professional on 11/21/2002, concerning a 65 year old female vaccinee who experienced upper extremity weakness, pain, swelling and tenderness from the site of administration at the deltoid muscle down to the fingertips, 16 days after receiving Fluvirin on 10/29/2002.  On 11/14/2002, the vaccinee's upper extremity became weak, painful, swollen and tender from the site of injection at the deltoid muscle down to the fingertips.  The vaccinee went to the physician as a result of this event, and was prescribed oral anti-inflammatory medication.  The event had partially resolved at the time of reporting, but was still present.  The vaccinee did not received any other injections in the affected upper extremity either before or after the Fluvirin injection.  The vaccinee has received Fluvirin in previous years without any adverse or untoward event.  The vaccinee has no known medciation or other allergies.  The reporter has assessed the relationship of the vaccine to the vent as probable.  Update 1, 12/10/2002:  An update report received from a healthcare professional indicated that the vaccinee did not experience soreness, swelling, redness or bruising at the injection site.  However, 16 days after receiving Fluvirin, the vaccinee experienced pain in the right arm to touch and was having difficulty lifting her right arm.  The vaccinee was treated with 7.5mg melocain bid.  At the time of reporting the vaccinee had not yet recovered.  The vaccinee's physician suggested that the event was an adverse reaction to the Fluvirin.
Age: 54.0
Sex: M
Vaccine: FLU3
Symptoms: Erythema, Injection site reaction, Injection site swelling
Clinical narrative: A report was received from a healthcare professional on 11/21/2002, concerning a 54 year old male vaccinee who experienced an injection site reaction after receiving Fluvirin on 11/19/2002. On an unknown date the vaccinee experienced an injection site reaction after receiving Fluvirin on 11/19/2002.  The vaccinee's upper arm became red and swollen, and the area around the injection site was swollen.  At the time of reporting the outcome of the event was unknown. There was insufficient information to determine the reporter's causality assessment.
Age: 10.0
Sex: M
Vaccine: FLU3
Symptoms: Cough, Pyrexia
Clinical narrative: A report was received from a healthcare professional who is also the vaccinee's father on 11/22/2002 concerning a 10 year old male vaccinee who experienced an upper respiratory cough and fever 2 days after receiving Fluvirin on 11/19/2002.  On 11/21/2002 the vaccinee began to experience an upper respiratory cough and a mild fever.  The vaccinee had been exposed to other people with coughs and colds.  At the time of the report the vaccinee had not recovered. The reporter has assessed the relationship of the vaccine to the event as unrelated.  The reporter indicated that a possible reason was the vaccinee's exposure to other children experiencing similar symptoms and not due to Fluvirin.
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 11/22/2002 concerning a group of vaccinees less than 4 years old of unknown sex who inadvertently received Fluvirin from approximately 11/07/2002 onwards.  From 11/07/2002 Fluvirin was administered to vaccinees less than 4 years old.  There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/10/2002: A follow report was received from a healthcare professional on 12/10/2002 indicating that an 11 month old male vaccinee was inadvertently administered Fluvirin intramuscularly on 11/12/2002.
Age: 78.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 21Nov02 concerning a eleven vaccinees between the ages of 56 and 84 years who were inadvertently administered 1ml of Fluvirin on an unreported date. On an unreported date a eleven vaccinees were inadvertently administered 1ml of Fluvirin. No adverse reaction was reported. There was insufficient information to determine the reporter's causality assessment. Update 1 31Dec02: A follow up report was received from a health care professional indicating that a 78 year old male vaccinee was inadvertently administered 1.0ml of Fluvirin on 21Nov02. Cross reference with: PJP200200906, PJP200200905, PJP200200904, PJP200200903, PJP200200902, PJP200200901, PJP200200900, PJP200200899, PJP200200898, PJP200200907.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site vesicles
Clinical narrative: A report was received from a healthcare professional on 25Nov02, concerning a 57 year old female vaccinee who experienced a blister at the injection site 8 days after receiving a Fluvirin injection in the right deltoid on 12Nov02. On 20Nov02 the vaccinee reported a blister at the injection site which scabbed over and had resolved at the time of reporting. The reporter has assessed the relationship of the vaccine to the event as probable.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Blister, Petechiae, Pruritus, Sunburn
Clinical narrative: A report was recieved from a consumer on 27Nov02, concerning a 67 year old female vaccinee who experienced blisters on her body within one week of receiving 0.5ml Fluvirin vaccine 0.5ml IM on 31Oct02. Within one week the vaccinee developed a severe outbreak of blisters on the body including the face, arms, legs and trunk. On 06 or 07Nov02 the vaccinee was seen by a physician who prescribed an unk antibiotic. On 14Nov02 the vaccinee was referred to a dermatologist who suggested that thimerosal in Fluvirin vaccine might have caused the adverse event. The dermatologist prescribed prednisone 5mg six times a day. On 21Nov, a culture was taken from the blisters. The culture results were not available at the time of reporting. On 25Nov02, the vaccinee had a follow up appt with the dermatologist, who subsequently increased the dose of prednisone to 40mg daily for 1 week. The vaccinee stated that prednisone had not relieved the symptoms and that she had applied unk antibiotic cream and foam to the blisters to reduce itchiness. According to the vaccinee her face looked and felt sunburned, scabs from the blisters were deep and large leaving some scars. The vaccinee also reported petechiae on both feet, legs and inside of forearms, but no local reaction at the injection site. The vaccinee had received the flu vaccine for at least 10 years without any problem and is not allergic to any medicine except Betadine. The vaccinee has used Nerthiolate for many years without any problem.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a health care professional on 02Dec02, concerning an unk number of vaccinees aged between 6-35 months who were inadvertently administered Fluvirin. On unk dates between 21Oct02 and 02Dec02, an unk number of vaccinees aged between 6-35 months were inadvertently administered Fluvirin. The vaccinees were administered Fluvirin once if they had recieved it before and twice if they had not. No adverse symptoms were reported. There was insufficient information to determine the reporter's causality assessment. Cross reference with PJP200300007.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a healthcare professional on 02Dec02, concerning an unk number of vaccinees of less than 4 years of age who were inadvertently administered Fluvirin. On unk dates, an unk number of vaccinees of less than 4 years of age were inadvertently administered Fluvirin. There was insufficient information to determine the reporter's causality assessment.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Muscle twitching, Neck pain, Neurological symptom
Clinical narrative: A report was received from a consumer on 04Dec02 concerning a 56 year old female vaccinee who experienced neurological pain and twinges in her neck 2 hours after Fluvirin vaccination on 21Nov02. On 21Nov02, the vaccinee experienced neurological pain and twinges in her neck. The symptoms occurred periodically over the course of 10 days. The vaccinee self administered Advil analgesia and applied ice to the affected areas of neck. The events were not reported to her physician. At the time of the report the symptoms had subsided and the event had resolved.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Neck pain
Clinical narrative: A report was received from a consumer on 04Dec02, concerning a 59 year old female vaccinee who experienced a pinched neck two days after receiving Fluvirin on 29Nov02. On 01Dec02 the vaccinee experienced a pinched neck. The vaccinee described the pain as muscular pain at the back of the neck, which was more evident upon bending. The vaccinee described the pain as still occurring but with a decreased severity. The vaccinee last received the influenza vaccine in Nov01 and did not recall as having a similar type of reaction.
Sex: U
Vaccine: FLU3
Symptoms: Fatigue, Medication residue, Nausea, Vomiting
Clinical narrative: A report received from a health care professional on 06Dec02, concerning 30-40 vaccinees who experienced tapioca like objects in stools, mild fatigue, nausea and vomiting after receiving Fluvirin between October and November 2002. On 17Oct02 and 24Oct02, staff members at a long term care facility received Fluvirin and on 07Nov02, the residents at the facility received Fluvirin. Between 20-22 Nov02, 30-40 vaccinees experienced tapioca like objects in stools, mild fatigue, nausea and vomiting after receiving Fluvirin. The family members of the affected staff members also experienced the same symptoms. Tests on the stools, water system and other relevant equipment around the facility were negative for virus, parasite and bacterial contamination. The reporter indicated that the Fluvirin vaccine vials were left at room temp overnight, and then subsequently stored in a refrigerator until administration. The vaccinees have not yet recovered at the time of reporting. The reporter has assessed the relationship of the vaccine to the event as possible.
Age: 47.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Injection site pain
Clinical narrative: A report was received from a health care professional on 09Dec02 concerning a 47 year old male vaccinee who experienced pain and weakness on the anterior, middle and posterior left deltoid 10 to 14 days after receiving Fluvirin in the week beginning 04Nov02. Ten to fourteen days after receiving 0.5ml Fluvirin IM on the 04Nov02 the vaccinee experienced pain and weakness on the anterior, middle and posterior left deltoid. At the time of reporting it was reported that 80% of the pain had resolved and the weakness had resolved completely. There was insufficient information to determine the reporters causality assessment.
Age: 11.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Pain
Clinical narrative: A report was received from a health care professional on 09Dec02 concerning a 11 year old male vaccinee who experienced bilateral pain and weakness at the triceps which began 2 weeks after administration of Fluvirin in the week beginning 28Oct02. Two weeks after receiving 0.5ml Fluvirin IM in the week beginning on the 28Oct02 the vaccinee experienced bilateral pain and weakness at the triceps. Fluvirin was administered on the right deltoid. At the time of reporting it was reported that the pain and weakness had resolved 100%. There was insufficient information to determine the reporters causality assessment. Cross reference with: PJP200200836.
Age: 80.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 09Dec02 concerning a 80 year old female vaccinee who inadvertently received a dose of Fluvirin on 20Nov02 and 08Dec02. On 20Nov02 and 08Dec02 the vaccinee received vaccinations of 0.5ml Fluvirin. No adverse reaction was reported. There was insufficient information to determine the reporter's causality assessment.
Age: 90.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site oedema
Clinical narrative: A report was received from a vaccinees daughter on 09Dec02 regarding a 90 year old female vaccinee who experienced a fingertip size swelling at the injection site 2 days after receiving Fluvirin on 04Dec02. On 06Dec02 the vaccinee experienced a fingertip size swelling at the injection site. The vaccinee had no decrease in arm mobility and no pain was experienced. The event had not resolved at the time of reporting.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling hot, Injection site erythema, Injection site pain
Clinical narrative: A report was received from a healthcare professional on 10Dec02, concerning a 66 year old female vaccinee who experienced soreness, redness, and warmth at injection site within one day of receiving Fluvirin on 12Jun02. On the evening of 12Jun02 the vaccinee c/o soreness at the injection site. The next morning the site was described as being very red and warm to the touch. At the time of reporting, the symptoms were resolving and the vaccinee had not yet recovered from the event. The reporter has assessed the relationship of the vaccine to the event as possible.
Age: 1.07
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicated that a 13 month old female was inadvertently administered Fluvirin IM on 21Nov02. Cross reference: PJP200200805, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200863, PJP200200864, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Age: 0.76
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicated that a 9 month old female was inadvertently administered Fluvirin IM on 18Nov02. Cross reference: PJP200200848, PJP200200805,  PJP200200850, PJP200200851, PJP200200852,PJP200200853,PJP200200854,PJP200200855,PJP200200856,PJP200200857,PJP200200858,PJP200200859,PJP200200860,PJP200200861,PJP200200862,PJP200200863,PJP200200864,PJP200200866,PJP200200867,PJP200200868,PJP200200869,PJP200200870,PJP200200871,PJP200200872,PJP200200873,PJP200200874,PJP200200875,PJP200200876,PJP200200877.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicated that a 2 year old male vaccinee was inadvertently administered Fluvirin IM on 20Nov02. Cross reference: PJP200200848, PJP200200805,  PJP200200849, PJP200200851, PJP200200852,PJP200200853,PJP200200854,PJP200200855,PJP200200856,PJP200200857,PJP200200858,PJP200200859,PJP200200860,PJP200200861,PJP200200862,PJP200200863,PJP200200864,PJP200200866,PJP200200867,PJP200200868,PJP200200869,PJP200200870,PJP200200871,PJP200200872,PJP200200873,PJP200200874,PJP200200875,PJP200200876,PJP200200877.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 22Nov02 concerning a group of vaccinees less than 4 years old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporters causality assessment. Update 1 10Dec02: A follow up report was received by a health professional indicating that a 24 month old male vaccinee was inadvertently administered Fluvirin IM on 23Nov02. Cross reference with: PJP200200848, PJP200200849,PJP200200850,PJP200200805,PJP200200852, PJP200200853,PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859,PJP200200860, PJP200200861,PJP200200862, PJP200200863,PJP200200864, PJP200200865,PJP200200866,PJP200200867,PJP200200868,PJP200200869, PJP200200870, PJP200200871,PJP200200872,PJP200200873,PJP200200874,PJP200200875,PJP200200876,PJP200200877.
Age: 0.92
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 22Nov02 concerning a group of vaccinees less than 4 years old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicating that an 11 and a half month old male was inadvertently administered Fluvirin IM on 12Nov02. Cross reference: PJP200200848,  PJP200200849, PJP200200850, PJP200200851, PJP200200805, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857,PJP200200858,PJP200200859,PJP200200860,PJP200200861,PJP200200862,PJP200200863,PJP200200864,PJP200200866,PJP200200867,PJP200200868,PJP200200869,PJP200200870,PJP200200871,PJP200200872,PJP200200873,PJP200200874,PJP200200875,PJP200200876,PJP200200877.
Age: 4.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received form a health care professional on 11/22/2002 concerning a group of vaccinees less than 4 years old of unknown demography who inadvertently received Fluvirin from approximately 11/07/2002-onwards. From 11/07/2002 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporters causality assessment. Update1. 12/10/2002: A follow up report was received from a health professional indicating that a 4 year old male vaccinee was inadvertently administered Fluvirin intramuscularly on 11/14/2002. Cross Reference with: PJP-2002-00848, PJP-2002-00849, PJP-2002-00850, PJP-2002-00851, PJP-2002-00852, PJP-2002-00854, PJP-2002-00805, PJP-2002-00855, PJP-2002-00856, PJP-2002-00857, PJP-2002-00858, PJP-2002-00859, PJP-2002-00860, PJP-2002-00861, PJP-2002-00862, PJP-2002-00863, PJP-2002-00864, PJP-2002-00865, PJP-2002-00866, PJP-2002-00867, PJP-2002-00868, PJP-2002-00869, PJP-2002-00870, PJP-2002-00871, PJP-2002-00872, PJP-2002-00873, PJP-2002-00874, PJP-2002-00875, PJP-2002-00876, PJP-2002-00877.
Age: 27.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/22/2002, concerning a group of vaccinees less than 4 years old of unknown demography, who inadvertently received Fluvirin from approximately 11/07/2002-onwards. From 11/07/2002, Fluvirin was administered to vaccinees less than 4 years old, There were no reported adverse events. There was insufficient information to determine the reporters causality assessment. Update1. 12/10/2002: A follow up report was received from a health professional indicating that a 27 month old female vaccinee was inadvertently administered Fluvirin intramuscularly on 11/14/2002. Cross Reference with: PJP200200848,PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200805, PJP2002856, PJP20020857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200863, PJP200200864, PJP200200865, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Age: 1.58
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/22/02, concerning a group of vaccinees less than 4 years old of unknown demography who inadvertently received Fluvirin from approximately 11/07/02 onwards. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update (1) 12/10/02: A follow up report was received from a health care professional indicating that a 19 month old male vaccine was inadvertently administered Fluvirin intramuscularly on 11/20/02. Cross reference with: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200805, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200863, PJP200200864, PJP200200864, PJP200200865, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200876 and PJP200200877.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/22/2002 concerning a group of vaccinees less than 4 years old of unknown demography who inavertently received Fluvirin from approximately 11/07/2002 onwards. From 11/07/2002 Fluvirin was administered to vaccinees less than 4 years old. There were no adverse events. There was insufficient information to determine the reporters causality assessment.  Follow up 1. 12/10/2002: A follow up report was received from a health care professional indicating that a  2 year old female vaccinee was inadvertnetly administered Fluvirin intramuscularly on 11/19/2002. Cross Reference with: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200864, PJP200200865, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/22/2002 concerning a group of vaccinees less than 4 years old of unknown demography who inadvertently received Fluvirin from approximately 11/07/2002 onwards. From 11/07/2002 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporters causality assessment.  Update1. 12/10/2002: A follow up report was received from a health care professional on 12/10/2002 indicating that a 3 year male vaccinee was inadvertently administered Fluvirin intramuscularly on 11/19/2002. the vaccinee experienced no adverse reactions. Cross Reference with; PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200853, PJP200200854, PJP200200855, PJP200300856, PJP200200805, PJP200200806, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200863, PJP200200864, PJP200200865, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200300872, PJP200200873, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/22/2002 concerning a group of vaccinees less than 4 years old of unknown demography who inadvertently received Fluvirin from approximately 11/07/2002 onwards. From 11/07/2002 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events.  There was insufficient information to determine the reporters causality assessment. Update1 12/10/2002: A follow up report was received from a health care professional on 12/10/2002 indicating that a 09 month old female vaccinee was inadvertently administered Fluvirin intramuscularly on 11/19/2002. The vaccinee experienced no adverse reactions. Cross Reference with: PJP200200848, PJP200200849, PJP200200850, PJP00851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200805, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200863, PJP200200864, PJP200200865, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870
Age: 1.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/22/2002 concerning a group of vaccinees less than 4 years old of unknown demography who inadvertently received Fluvirin from approximately 11/07/2002 onwards. From 11/07/2002 Fluvirin was administered to vaccinees less than 4 years old.. There were no reported adverse events. There was insufficient information to determine the reporters causality assessment.  Update1. 12/10/2002:  A follow up report from a health care professional indicating that a 1 year old female vaccinee was inadvertently administered Fluvirin intramuscularly on 11/18/2002. The vaccinee experienced no adverse reactions. Cross Reference with:PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200805, PJP200200860, PJP200200861, PJP200200862, PJP200200863, PJP200200864, PJP200200865, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP20000875, PJP200200876, PJP200200877.
Age: 1.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicated that a 1 year old female was inadvertently administered Fluvirin IM on 18Nov02.  The vaccinee experienced no adverse reaction. Cross reference: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854,PJP200200855, PJP200200856,PJP200200857,PJP200200858, PJP200200859, PJP200200805, PJP200200861, PJP200200862, PJP200200863, PJP200200864, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from ah health care professional on 11/22/2002 concerning a group of vaccinees less than 4 years old of unknown demography who inadvertently received Fluvirin from approximately 11/07/2002 onwards. From 11/07/02002 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporters causality assessment. Update1. 12/10/2002: A follow up report was received from a health care professional on 12/10/2002 indicating that a 9 month old male vaccinees who was inadvertently administered Fluvirin intramuscularly on 11/15/2002. The vaccinees experienced no adverse reactions. Cross Reference with: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200805, PJP200200862, PJP200200863, PJP200200864, PJP200200865, PJP200200866, PJP20020867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP20200873, PJP2000200874, PJP200200875, PJP200200876, PJP200200877.